Label-free multiphoton imaging of β-amyloid plaques in Alzheimer’s disease mouse models

Abstract. β-Amyloid (Aβ) plaque, representing the progressive accumulation of the protein that mainly consists of Aβ, is one of the prominent pathological hallmarks of Alzheimer’s disease (AD). Label-free imaging of Aβ plaques holds the potential to be a histological examination tool for diagnosing AD. We applied label-free multiphoton microscopy to identify extracellular Aβ plaque as well as intracellular Aβ accumulation for the first time from AD mouse models. We showed that a two-photon-excited fluorescence signal is a sensitive optical marker for revealing the spatial–temporal progression and the surrounding morphological changes of Aβ deposition, which demonstrated that both extracellular and intracellular Aβ accumulations play an important role in the progression of AD. Moreover, combined with a custom-developed image-processing program, we established a rapid method to visualize different degrees of Aβ deposition by color coding. These results provide an approach for investigating pathophysiology of AD that can complement traditional biomedical procedures.

[1]  Mary M. Maleckar,et al.  Label-free prediction of three-dimensional fluorescence images from transmitted light microscopy , 2018 .

[2]  Hui Gong,et al.  Label-free brainwide visualization of senile plaque using cryo-micro-optical sectioning tomography. , 2017, Optics letters.

[3]  P. A. Peterson,et al.  Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease , 2001, Histopathology.

[4]  W. Webb,et al.  Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Yong Jeong,et al.  GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease , 2014, Nature Medicine.

[6]  B. Hyman,et al.  Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy‐X04, a Systemically Administered Congo Red Derivative , 2002, Journal of neuropathology and experimental neurology.

[7]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[8]  George Perry,et al.  Senile plaque composition and posttranslational modification of amyloid-β peptide and associated proteins , 2002, Peptides.

[9]  Xiaoqin Zhu,et al.  Spatial and temporal identification of cerebral infarctions based on multiphoton microscopic imaging. , 2018, Biomedical optics express.

[10]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[11]  Yasuo Ihara,et al.  Immunocytochemical study on senile plaques in Alzheimer's disease. II. Abnormal dendrites in senile plaques as revealed by antimicrotubule-associated proteins (MAPs) immunostaining. , 1983 .

[12]  James C. Vickers,et al.  Defining the Earliest Pathological Changes of Alzheimer’s Disease , 2016, Current Alzheimer research.

[13]  Michael Garwood,et al.  In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent , 2004, Magnetic resonance in medicine.

[14]  Yasuo Ihara,et al.  Immunocytochemical Study on Senile Plaques in Alzheimer's Disease. II , 1983 .

[15]  Jin Woo Choi,et al.  350-μm side-view optical probe for imaging the murine brain in vivo from the cortex to the hypothalamus , 2013, Journal of biomedical optics.

[16]  M. Villiger,et al.  Label-Free Imaging of Cerebral β-Amyloidosis with Extended-Focus Optical Coherence Microscopy , 2012, The Journal of Neuroscience.

[17]  Shuangmu Zhuo,et al.  Multimode nonlinear optical imaging of the dermis in ex vivo human skin based on the combination of multichannel mode and Lambda mode. , 2006, Optics express.

[18]  M. Monici.  Cell and tissue autofluorescence research and diagnostic applications. , 2005, Biotechnology annual review.

[19]  Valerio Zerbi,et al.  Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model , 2013, Neurobiology of Aging.

[20]  Stephen B. Dunnett,et al.  Transgenic mouse models of Alzheimer's disease , 2005 .

[21]  V. Lee,et al.  Amyloid binding ligands as Alzheimer’s disease therapies , 2002, Neurobiology of Aging.

[22]  Nozomi Nishimura,et al.  Three-photon excited fluorescence imaging of unstained tissue using a GRIN lens endoscope , 2013, Biomedical optics express.

[23]  Brian J. Bacskai,et al.  Label-free imaging of amyloid plaques in Alzheimer’s disease with stimulated Raman scattering microscopy , 2018, Science Advances.

[24]  Tetsuya Suhara,et al.  Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography , 2007, The Journal of Neuroscience.

[25]  Hartwig Wolburg,et al.  Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology , 2006, EMBO reports.

[26]  Yuanxiang Lin,et al.  Optical Visualization of Cerebral Cortex by Label-Free Multiphoton Microscopy , 2019, IEEE Journal of Selected Topics in Quantum Electronics.

[27]  Peihua Lin,et al.  Diagnosing pituitary adenoma in unstained sections based on multiphoton microscopy , 2018, Pituitary.

[28]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[29]  Dae Hwan Kim,et al.  Label-free imaging and quantitative chemical analysis of Alzheimer’s disease brain samples with multimodal multiphoton nonlinear optical microspectroscopy , 2015, Journal of biomedical optics.

[30]  S. DeKosky,et al.  Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice. , 2009, Letters in drug design & discovery.

[31]  Ottavio Arancio,et al.  Progressive age‐related development of Alzheimer‐like pathology in APP/PS1 mice , 2004, Annals of neurology.

[32]  Heping Cheng,et al.  Fast high-resolution miniature two-photon microscopy for brain imaging in freely behaving mice , 2017, Nature Methods.

[33]  Brian J Bacskai,et al.  In Vivo Imaging of Reactive Oxygen Species Specifically Associated with Thioflavine S-Positive Amyloid Plaques by Multiphoton Microscopy , 2003, The Journal of Neuroscience.

[34]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.

[35]  David A. Boas,et al.  In vivo imaging of cerebral energy metabolism with two-photon fluorescence lifetime microscopy of NADH , 2013, Biomedical optics express.

[36]  J. D. McGaugh,et al.  Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice , 2005, Neuron.

[37]  C. A. Wiley,et al.  A Dynamic Relationship between Intracellular and Extracellular Pools of Aβ , 2007 .

[38]  Watt W Webb,et al.  Optical visualization of Alzheimer's pathology via multiphoton-excited intrinsic fluorescence and second harmonic generation. , 2009, Optics express.

[39]  Weilin Wu,et al.  Rapid, label‐free identification of cerebellar structures using multiphoton microscopy , 2017, Journal of biophotonics.

[40]  K. Duff,et al.  Quantitative histological analysis of amyloid deposition in Alzheimer’s double transgenic mouse brain , 2000, Neuroscience.

[41]  Irene Georgakoudi,et al.  Automated quantification of three-dimensional organization of fiber-like structures in biological tissues. , 2017, Biomaterials.